Drug-eluting stent use with abbreviated dual antiplatelet therapy after percutaneous coronary intervention for liver transplantation evaluation

被引：5
|
作者：
Koshy, Anoop N. [1 ,2 ]
Rodrigues, Thalys Sampaio [1 ,2 ]
Gow, Paul J. [2 ,3 ]
Cailes, Benjamin [1 ]
VanWagner, Lisa B. [4 ]
Farouque, Omar [1 ,2 ]
机构：
[1] Austin Hlth, Dept Cardiol, Melbourne, Vic, Australia
[2] Univ Melbourne, Parkville, Vic, Australia
[3] Austin Hosp, Victorian Liver Transplant Unit, Melbourne, Vic, Australia
[4] Univ Texas Southwestern Med Ctr Dallas, Dept Med, Div Digest & Liver Dis, Dallas, TX 75390 USA
来源：
LIVER TRANSPLANTATION | 2023年 / 29卷 / 04期
基金：
英国医学研究理事会;
关键词：
D O I：
10.1097/LVT.0000000000000090
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：459 / 462
页数：4
相关论文
共 50 条
  • [1] The Optimal Strategy of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stent
    Hu, Mengjin
    Gao, Xiaojin
    Yang, Jingang
    Yang, Yuejin
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [2] Compliance With Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Drug-Eluting Stents
    de Sa, Daniel D. Correa
    Lennon, Ryan J.
    Bresnahan, John F.
    Rihal, Charanjit S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A371 - A371
  • [3] Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis
    Yin, Shang-He-Lin
    Xu, Peng
    Wang, Bian
    Lu, Yao
    Wu, Qiao-Yu
    Zhou, Meng-Li
    Wu, Jun-Ru
    Cai, Jing-Jing
    Sun, Xin
    Yuan, Hong
    BMJ-BRITISH MEDICAL JOURNAL, 2019, 365
  • [4] What Is the Optimal Dual Antiplatelet Therapy Strategy After Percutaneous Coronary Intervention in the Era of New-Generation Drug-Eluting Stent?
    Yokoyama, Hiroaki
    CIRCULATION JOURNAL, 2020, 84 (09) : 1459 - 1460
  • [5] Antiplatelet therapy in the era of percutaneous coronary intervention with drug-eluting balloons
    Bonaventura, Klaus
    Sonntag, Steffen
    Kleber, Franz X.
    EUROINTERVENTION, 2011, 7 : K106 - K111
  • [6] Safety of short-term dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting balloons
    Bonaventura, K.
    Sonntag, S.
    Fengler, A.
    Roettgen, A.
    Kleber, F. X.
    EUROPEAN HEART JOURNAL, 2011, 32 : 244 - 244
  • [7] Benefits and risks of prolonged dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent in patients with stable coronary artery disease and diabetes
    崔孔勇
    China Medical Abstracts(Internal Medicine), 2022, 39 (03) : 162 - 162
  • [8] Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stent Implantation - Meta-Analysis of Randomized Controlled Trials
    Khalid, Muhammad Faisal
    Khan, Abdul Ahad
    Murtaza, Ghulam
    Paul, Timir K.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (04) : S15 - S15
  • [9] Dual antiplatelet therapy in the drug-eluting stent era
    Wallentim, Lars
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2008, 10 (0D) : D38 - D44
  • [10] The optimal duration of dual antiplatelet therapy in patients receiving percutaneous coronary intervention with drug-eluting stents
    Sheyin, O.
    Perez, X.
    Pierre-Louis, B.
    Kurian, D.
    EUROPEAN HEART JOURNAL, 2015, 36 : 512 - 512
12345